Royalty Pharma reports second quarter 2026 results
Go back to Royalty Pharma reports second quarter 2026 results| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 56.77 -0.49 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.26 | 52 Week High | $3.48 | |||
| Open | $57.44 | 52 Week Low | $0.80 | |||
| Day High | $57.66 | P/E | N/A | |||
| Day Low | $56.60 | EPS | $-1.54 | |||
| Volume | 4,159,406 | |||||

